Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Manufacturers Share Doubts About FDA’s ISO 13485 Audit Report Program

This article was originally published in The Gray Sheet

Executive Summary

A voluntary new FDA program aims to relieve the inspectional load on manufacturers and the agency. But some device companies are skeptical that anyone will participate.

You may also be interested in...

Device Harmonization Efforts In Asia Still Far From Implementation And Enforcement

After a decade of work, the Global Harmonization Task Force concludes its mission to align medical device regulations, but how far off is implementation?

Regulatory News In Brief

FDA issues documents on advisory committee financial conflicts and scientific integrity. More regulatory updates.

Senate Drug Pricing Bill Lowers Manufacturer Discounts In Part D Catastrophic Phase

Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts